Page last updated: 2024-08-22

ruthenium and Alzheimer Disease

ruthenium has been researched along with Alzheimer Disease in 18 studies

Research

Studies (18)

TimeframeStudies, this research(%)All Research%
pre-19901 (5.56)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (16.67)24.3611
2020's14 (77.78)2.80

Authors

AuthorsStudies
Cen, J; Chen, X; Gong, Y; Guo, X; Huang, Y; Jia, Z; Li, J; Liu, J; Liu, Y; Yuan, X1
Apuzzo, CF; Bothwell, PJ; Ferrence, GM; Hamaker, CG; Huffman, SE; Jones, MA; Oliver, EB; Platt, DC; Strandquist, ET; Webb, MI; Weitzel, CS; Will, MF; Yawson, GK1
Angeletti, M; Bonfili, L; Cecarini, V; Cuccioloni, M; Eleuteri, AM; Pagliaricci, N; Petetta, L; Pettinari, R; Tombesi, A1
Bhattacharya, U; Chen, HJ; Kong, KV; Lin, D; Liu, YH; Tai, HC; Tsai, SW; Wu, CY; Wu, YC1
Cao, J; Li, Z; Liu, C; Song, Z; Sun, Y; Wei, D; Yan, J; Yu, H; Zhang, H1
Bothwell, PJ; Ehlbeck, JT; Garcia, JA; Grimard, DM; Hacker, RM; Jones, MA; Wall, BJ; Webb, MI1
Gong, Y; Huang, A; Liu, J; Liu, Y; Wei, JA; Yuan, G; Zhang, L; Zhou, H; Zhu, X1
Hu, X; Liu, W; Shi, S; Tu, Y; Yao, T; Zhou, L1
Bothwell, PJ; Fisher, SS; Hamaker, CG; Huffman, SE; Jones, MA; Platt, DC; Webb, MI; Yawson, GK1
Bothwell, PJ; Ferrence, GM; Fisher, SS; Hamaker, CG; Huffman, SE; Jones, MA; Platt, DC; Webb, MI; Yawson, GK1
Cali, MP; Carlos, RM; Pereira, LMB; Rodrigues, EG; Sellani, TA; Teodoro, MD1
Apuzzo, CF; Bothwell, PJ; Ferrence, GM; Jones, MA; Platt, DC; Wall, BJ; Webb, MI; Will, MF; Yawson, GK1
Almeida, MP; Carlos, RM; de Jesus, HCR; Kock, FVC; Venâncio, T1
Peng, YB; Tan, CP; Tao, C; Zhao, P1
Bhat, SS; Jani, V; Joshi, B; Joshi, RR; Kulkarni, PP; Kumbhar, AS; Ramteke, SN; Sonawane, UB; Vyas, NA1
Arcisio-Miranda, M; Cali, MP; Carlos, RM; Carlos-Lima, E; Ito, AS; Pazin, WM; Salles Trevisan, MT; Silva, DE; Venâncio, T1
Anzini, P; Cini, R; Gabbiani, C; Gaggelli, E; Gaggelli, N; Kozlowski, H; Messori, L; Michelucci, E; Tamasi, G; Valensin, D; Valensin, G1
Lara, S; Nochlin, D; Snow, AD; Wight, TN1

Other Studies

18 other study(ies) available for ruthenium and Alzheimer Disease

ArticleYear
A diselenide bond-containing ROS-responsive ruthenium nanoplatform delivers nerve growth factor for Alzheimer's disease management by repairing and promoting neuron regeneration.
    Journal of materials chemistry. B, 2021, 09-29, Volume: 9, Issue:37

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Biocompatible Materials; Blood-Brain Barrier; Brain; Cell Line, Tumor; Drug Carriers; Hemolysis; Humans; Infrared Rays; Nanostructures; Nerve Growth Factor; Nerve Regeneration; Neuronal Outgrowth; Reactive Oxygen Species; Ruthenium; Selenium

2021
A Dual-Pronged Approach: A Ruthenium(III) Complex That Modulates Amyloid-β Aggregation and Disrupts Its Formed Aggregates.
    Inorganic chemistry, 2022, Feb-14, Volume: 61, Issue:6

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Cell Survival; Coordination Complexes; Dose-Response Relationship, Drug; Humans; Models, Molecular; Molecular Conformation; Neuroprotective Agents; Oxazoles; Protein Aggregates; Rats; Ruthenium; Structure-Activity Relationship; Tumor Cells, Cultured

2022
Enhancing the Amyloid-β Anti-Aggregation Properties of Curcumin via Arene-Ruthenium(II) Derivatization.
    International journal of molecular sciences, 2022, Aug-05, Volume: 23, Issue:15

    Topics: Alzheimer Disease; Amyloid; Amyloid beta-Peptides; Curcumin; Humans; Ruthenium

2022
Highly Efficient Singlet Oxygen Generation by BODIPY-Ruthenium(II) Complexes for Promoting Neurite Outgrowth and Suppressing Tau Protein Aggregation.
    Inorganic chemistry, 2023, Jan-23, Volume: 62, Issue:3

    Topics: Alzheimer Disease; Boron; Humans; Neuronal Outgrowth; Photosensitizing Agents; Protein Aggregates; Ruthenium; Singlet Oxygen; tau Proteins

2023
Visualization of the elevated levels of hypochlorous acid in Alzheimer's disease with a ruthenium(II) complex-based luminescence probe.
    Analytica chimica acta, 2023, Oct-23, Volume: 1279

    Topics: Alzheimer Disease; Fluorescent Dyes; Humans; Hypochlorous Acid; Luminescence; Ruthenium

2023
Finding the best location: Improving the anti-amyloid ability of ruthenium(III) complexes with pyridine ligands.
    Journal of inorganic biochemistry, 2024, Volume: 250

    Topics: Alzheimer Disease; Amines; Amyloid beta-Peptides; Humans; Ligands; Magnetic Resonance Spectroscopy; Pyridines; Ruthenium

2024
Intelligently thermoresponsive flower-like hollow nano-ruthenium system for sustained release of nerve growth factor to inhibit hyperphosphorylation of tau and neuronal damage for the treatment of Alzheimer's disease.
    Biomaterials, 2020, Volume: 237

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Delayed-Action Preparations; Mice; Nerve Growth Factor; Phosphorylation; Ruthenium; tau Proteins

2020
Orientation-Inspired Perspective on Molecular Inhibitor of Tau Aggregation by Curcumin Conjugated with Ruthenium(II) Complex Scaffold.
    The journal of physical chemistry. B, 2020, 03-26, Volume: 124, Issue:12

    Topics: Alzheimer Disease; Amyloid; Amyloid beta-Peptides; Curcumin; Humans; Ruthenium; tau Proteins

2020
Ruthenium(iii) complexes containing thiazole-based ligands that modulate amyloid-β aggregation.
    Metallomics : integrated biometal science, 2020, 04-01, Volume: 12, Issue:4

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Cell Line, Tumor; Cell Survival; Coordination Complexes; Crystallography, X-Ray; Humans; Ligands; Microscopy, Electron, Transmission; Peptide Fragments; Protein Aggregates; Rats; Ruthenium; Structure-Activity Relationship; Thiazoles

2020
Ruthenium(III) complexes with imidazole ligands that modulate the aggregation of the amyloid-β peptide via hydrophobic interactions.
    Journal of inorganic biochemistry, 2021, Volume: 214

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Coordination Complexes; Humans; Imidazoles; Protein Aggregates; Ruthenium

2021
Comparison of Aβ (1-40, 1-28, 11-22, and 29-40) aggregation processes and inhibition of toxic species generated in early stages of aggregation by a water-soluble ruthenium complex.
    Journal of inorganic biochemistry, 2021, Volume: 215

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Cell Survival; Coordination Complexes; Microscopy, Electron, Transmission; PC12 Cells; Peptide Fragments; Protein Aggregation, Pathological; Rats; Ruthenium; Solubility; Water

2021
Importance of Hydrogen Bonding: Structure-Activity Relationships of Ruthenium(III) Complexes with Pyridine-Based Ligands for Alzheimer's Disease Therapy.
    Journal of medicinal chemistry, 2021, 07-22, Volume: 64, Issue:14

    Topics: Alzheimer Disease; Animals; Cell Line, Tumor; Cell Survival; Coordination Complexes; Dose-Response Relationship, Drug; Humans; Hydrogen Bonding; Ligands; Molecular Structure; Neuroprotective Agents; Pyridines; Rats; Ruthenium; Structure-Activity Relationship

2021
Probing the acetylcholinesterase inhibitory activity of a novel Ru(II) polypyridyl complex and the supramolecular interaction by (STD)-NMR.
    Journal of inorganic biochemistry, 2021, Volume: 224

    Topics: Acetylcholinesterase; Alzheimer Disease; Cholinesterase Inhibitors; Coordination Complexes; Humans; Magnetic Resonance Spectroscopy; Molecular Structure; Pyridines; Ruthenium

2021
Inhibition of Aβ peptide aggregation by ruthenium(II) polypyridyl complexes through copper chelation.
    Journal of inorganic biochemistry, 2021, Volume: 224

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Benzimidazoles; Cell Line, Tumor; Cell Survival; Chelating Agents; Coordination Complexes; Copper; Humans; Mitochondria; Neurons; Oxyquinoline; Protein Aggregates; Protein Aggregation, Pathological; Reactive Oxygen Species; Ruthenium

2021
Ruthenium(II) polypyridyl complex as inhibitor of acetylcholinesterase and Aβ aggregation.
    European journal of medicinal chemistry, 2014, Mar-21, Volume: 75

    Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Cell Line, Tumor; Cholinesterase Inhibitors; Coordination Complexes; Humans; Organometallic Compounds; Phenanthrolines; Pyridines; Ruthenium

2014
Luminescent Ru(II) Phenanthroline Complexes as a Probe for Real-Time Imaging of Aβ Self-Aggregation and Therapeutic Applications in Alzheimer's Disease.
    Journal of medicinal chemistry, 2016, 10-13, Volume: 59, Issue:19

    Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Animals; Butyrylcholinesterase; Cell Line; Cholinesterase Inhibitors; Electrophorus; Humans; Luminescent Agents; Mice; Optical Imaging; Phenanthrolines; Protein Aggregates; Ruthenium

2016
fac-{Ru(CO)(3)}(2+) selectively targets the histidine residues of the beta-amyloid peptide 1-28. Implications for new Alzheimer's disease treatments based on ruthenium complexes.
    Inorganic chemistry, 2010, Jun-07, Volume: 49, Issue:11

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Circular Dichroism; Drug Design; Histidine; Humans; Magnetic Resonance Spectroscopy; Molecular Conformation; Organometallic Compounds; Peptide Fragments; Ruthenium; Spectrometry, Mass, Electrospray Ionization

2010
Cationic dyes reveal proteoglycans structurally integrated within the characteristic lesions of Alzheimer's disease.
    Acta neuropathologica, 1989, Volume: 78, Issue:2

    Topics: Alzheimer Disease; Humans; Indoles; Microscopy, Electron; Organometallic Compounds; Proteoglycans; Ruthenium; Ruthenium Red; Staining and Labeling

1989